Japanese Clinical Practice Guidelines for Vascular Anomalies 2017

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017
复制标题

DOI:
10.1111/1346-8138.15189
复制
发表时间:
2020-03
期刊:
The Journal of Dermatology
影响因子:
--
通讯作者:
H. Mimura;S. Akita;A. Fujino;M. Jinnin;Mine Ozaki;K. Osuga;H. Nakaoka;E. Morii;A. Kuramochi;Y. Aoki;Y. Arai;N. Aramaki;M. Inoue;Yuki Iwashina;T. Iwanaka;S. Ueno;A. Umezawa;M. Ozeki;J. Ochi;Y. Kinoshita;M. Kurita;Shien Seike;N. Takakura;Masataka Takahashi;T. Tachibana;K. Chuman;S. Nagata;M. Narushima;Y. Niimi;S. Nosaka;T. Nozaki;K. Hashimoto;A. Hayashi;S. Hirakawa;Atsuko Fujikawa;Y. Hori;K. Matsuoka;H. Mori;Yuki Yamamoto;S. Yuzuriha;N. Rikihisa;Shoji Watanabe;Shinichi Watanabe;T. Kuroda;S. Sugawara;K. Ishikawa;S. Sasaki
H. Mimura;S. Akita;A. Fujino;M. Jinnin;Mine Ozaki;K. Osuga;H. Nakaoka;E. Morii;A. Kuramochi;Y. Aoki;Y. Arai;N. Aramaki;M. Inoue;Yuki Iwashina;T. Iwanaka;S. Ueno;A. Umezawa;M. Ozeki;J. Ochi;Y. Kinoshita;M. Kurita;Shien Seike;N. Takakura;Masataka Takahashi;T. Tachibana;K. Chuman;S. Nagata;M. Narushima;Y. Niimi;S. Nosaka;T. Nozaki;K. Hashimoto;A. Hayashi;S. Hirakawa;Atsuko Fujikawa;Y. Hori;K. Matsuoka;H. Mori;Yuki Yamamoto;S. Yuzuriha;N. Rikihisa;Shoji Watanabe;Shinichi Watanabe;T. Kuroda;S. Sugawara;K. Ishikawa;S. Sasaki
中科院分区:
其他
文献类型:
--
作者:
H. Mimura;S. Akita;A. Fujino;M. Jinnin;Mine Ozaki;K. Osuga;H. Nakaoka;E. Morii;A. Kuramochi;Y. Aoki;Y. Arai;N. Aramaki;M. Inoue;Yuki Iwashina;T. Iwanaka;S. Ueno;A. Umezawa;M. Ozeki;J. Ochi;Y. Kinoshita;M. Kurita;Shien Seike;N. Takakura;Masataka Takahashi;T. Tachibana;K. Chuman;S. Nagata;M. Narushima;Y. Niimi;S. Nosaka;T. Nozaki;K. Hashimoto;A. Hayashi;S. Hirakawa;Atsuko Fujikawa;Y. Hori;K. Matsuoka;H. Mori;Yuki Yamamoto;S. Yuzuriha;N. Rikihisa;Shoji Watanabe;Shinichi Watanabe;T. Kuroda;S. Sugawara;K. Ishikawa;S. Sasaki

文献摘要

相似文献

目的是通过组织有效和高效的血管瘤和血管畸形治疗,确认治疗的安全性和系统化,采用基于证据的医学技术,并旨在改善结果,来准备实施当前最佳治疗的指南。临床问题(CQ)是根据重要的临床问题来决定的。在文献检索方面,为每个CQ设置已发表文献检索关键词,在PubMed、Cochrane Library和japan Centra Revuo Medicina数据库中检索1980年至2014年9月底发表的文献。通过系统评价获得的证据和建议的强度根据医疗信息网络分发系统技术确定。共使用33个CQ来编制建议,研究对象包括切除、硬化/栓塞、药物治疗、激光治疗、放疗等保守治疗的疗效、因病变部位和症状而适宜治疗的差异、适宜的治疗和检查时机、病理诊断决定诊断。因此,《2017年日本血管异常临床实践指南》已被编制为血管异常管理的循证指南。
The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes. Clinical questions (CQ) were decided based on the important clinical issues. For document retrieval, key words for published work searches were set for each CQ, and work published from 1980 to the end of September 2014 was searched in PubMed, Cochrane Library and Japana Centra Revuo Medicina databases. The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System technique. A total of 33 CQ were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence‐based guidelines for the management of vascular anomalies.